跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IO-1
首页
药物
IO-1
IO-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
SALTS AND CRYSTALS
EP 4211138 A4
申请人: KINOXIS THERAPEUTICS PTY LTD
优先权: 2020
EP
US
2 件公开
Novel style heterocyclic compound as insulin-like growth factors first type acceptor inhibitor
CN 1922147 A
申请人: ANALYTECON SA
优先权: 2004
CN
2 件公开
B7-H4 fusion proteins and methods of use thereof
US 9011853 B2
申请人: LANGERMANN SOLOMON
优先权: 2010
US
2 件公开
Preventives/remedies for cancer
US 2005106152 A1
申请人: HIKICHI YUICHI
优先权: 2001
US
Transdermal patches having a siliconic adhesive matrix stabilized with methacrylic copolymers
US 2006015077 A1
申请人: CILURZO FRANCESCO
优先权: 2002
US
Compositions and methods involving MDA-7 for the treatment of cancer
CN 101166539 B
申请人: UNIV TEXAS
优先权: 2006
CN
Chinese medicinal preparation, preparation and detection method thereof
CN 101209341 B
申请人: WENLONG YANG
优先权: 2006
CN
Palladium-103 and io-125 compound sealed seed source, source core and source core preparation method
CN 101797392 B
申请人: ATOM HIGH TECH CO LTD
优先权: 2010
CN
IRON OXIDE NANOCAPSULES, METHOD OF MANUFACTURING THE SAME, AND MRI CONTRAST AGENT USING THE SAME
US 2013164223 A1
申请人: JEON BONG-SIK
优先权: 2010
US
Bimodal imaging mediated treatment system for myocardial infarction as well as preparation method and application of bimodal imaging mediated treatment system
CN 114470242 A
申请人: GUANGZHOU MEGA MEDICAL BIOTECHNOLOGY CO LTD
优先权: 2022
CN
第 1 / 2 页
上一页
下一页
药物
反馈